Rapid Self AG Antigen Test Kit Flu Test Kit for Flu a/B

Product Details
Customization: Available
Classification: Biological Diagnostics
Type: Ivdr
Gold Member Since 2022

Suppliers with verified business licenses

Audited Supplier Audited Supplier

Audited by an independent third-party inspection agency

Management System Certification
ISO 13485, FSC
OEM/ODM Availability
Yes
  • Rapid Self AG Antigen Test Kit Flu Test Kit for Flu a/B
  • Rapid Self AG Antigen Test Kit Flu Test Kit for Flu a/B
  • Rapid Self AG Antigen Test Kit Flu Test Kit for Flu a/B
  • Rapid Self AG Antigen Test Kit Flu Test Kit for Flu a/B
  • Rapid Self AG Antigen Test Kit Flu Test Kit for Flu a/B
Find Similar Products

Basic Info.

Model NO.
FAB
Certification
ISO13485
Group
Ivdr
Transport Package
Cartons
Specification
2000pcs/carton
Trademark
no
Origin
China
HS Code
3822190090
Production Capacity
10000000000PCS/Year

Product Description

Rapid Self AG Antigen Test Kit Flu Test Kit for Flu A/B
Rapid Self AG Antigen Test Kit Flu Test Kit for Flu a/BRapid Self AG Antigen Test Kit Flu Test Kit for Flu a/B
Rapid Self AG Antigen Test Kit Flu Test Kit for Flu a/BRapid Self AG Antigen Test Kit Flu Test Kit for Flu a/BRapid Self AG Antigen Test Kit Flu Test Kit for Flu a/B
For professional and in vitro diagnostic use only.
 
[INTENDED USE]
The Influenza A+B Combo Rapid Test Cassette is a lateral flow
immunoassay intended for the qualitative detection of influenza A and
influenza B viral nucleoprotein antigens in nasopharyngeal swab and
oropharyngeal swab from individuals with signs and symptoms of
respiratory infection. It is intended to aid in the rapid differential diagnosis of
influenza A and B viral infections. The test is not intended to detect influenza
C antigens.
Positive results are indicative of active infection but do not rule out bacterial
infection or co-infection with other viruses; clinical correlation with patient
history and other diagnostic information is necessary to determine patient
infection status.
Negative test results are presumptive and it is recommended these results
be confirmed by viral culture or an influenza A and B molecular assay.
Negative results do not preclude influenza virus infections and should not be
used as the sole basis for treatment or other patient management decisions.

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now
Contact Supplier